varenicline has been researched along with Chemical Dependence in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 13 (68.42) | 24.3611 |
| 2020's | 4 (21.05) | 2.80 |
| Authors | Studies |
|---|---|
| Bhanot, S; Jia, L; Tsang, VWL | 1 |
| Kenny, PJ; O'Brien, CP; Pierce, RC; Swinford-Jackson, SE; Unterwald, EM; Vanderschuren, LJMJ | 1 |
| Ashare, R; Duerr, C; Hawk, LW; Mahoney, MC; Schlienz, N | 1 |
| Colby, SM; Leggio, L; Martin, RA; Monti, PM; Rohsenow, DJ; Swift, RM; Tidey, JW | 1 |
| Colby, SM; MacKillop, J; Martin, RA; Murphy, CM; Rohsenow, DJ; Tidey, JW | 1 |
| Crooks, PA; Dwoskin, LP; Kangiser, MM; Stairs, DJ; Zheng, G | 1 |
| Bullen, C; Galea-Singer, S; Kurdziel, T; Laking, G; Newcombe, D; Parag, V; Verbiest, M; Walker, N | 1 |
| Hughes, JR; Klemperer, EM; Naud, S | 1 |
| Camarasa, J; Ciudad-Roberts, A; Escubedo, E; Pubill, D | 1 |
| Coen, K; Funk, D; Lê, AD; Lo, S | 1 |
| Ballbè, M; Bruguera, E; Cano, M; Fernández, E; Fernández, T; Nieva, G; Raich, A | 1 |
| Klein, JW | 1 |
| Booij, J; Crunelle, CL; Miller, ML; van den Brink, W | 1 |
| Johnson, TS | 1 |
| Grief, SN | 1 |
| Marti, J | 1 |
| Anthony, JC; Behm, FM; Eaton, WW; Fisher, C; Ialongo, N; Musci, R; Rose, JE; Storr, CL; Uhl, GR; Walther, D | 1 |
| Billing, CB; Burstein, AH; McColl, SL; Reeves, KR; Sellers, EM; Stolar, M | 1 |
| Tyndale, R | 1 |
5 review(s) available for varenicline and Chemical Dependence
| Article | Year |
|---|---|
Study Characteristics Influence the Efficacy of Substance Abuse Treatments: A Meta-analysis of Medications for Smoking Cessation.
Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Humans; Smoking Cessation; Smoking Cessation Agents; Substance-Related Disorders; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2020 |
Pharmacotherapy for Substance Use Disorders.
Topics: Age Factors; Alcohol Deterrents; Alcoholism; Antidepressive Agents; Buprenorphine; Bupropion; Drug Therapy, Combination; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Recurrence; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2016 |
The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: a review.
Topics: Alcohol Drinking; Animals; Behavior, Addictive; Benzazepines; Brain; Dopamine; Drug Partial Agonism; Humans; Neurotransmitter Agents; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Secondary Prevention; Smoking Cessation; Substance-Related Disorders; Varenicline | 2010 |
A brief review of pharmacotherapeutic treatment options in smoking cessation: bupropion versus varenicline.
Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Risk Factors; Smoking Cessation; Smoking Prevention; Substance-Related Disorders; Varenicline | 2010 |
Nicotine dependence: health consequences, smoking cessation therapies, and pharmacotherapy.
Topics: Administration, Cutaneous; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Heart Diseases; Humans; Neoplasms; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Substance-Related Disorders; Varenicline | 2011 |
5 trial(s) available for varenicline and Chemical Dependence
| Article | Year |
|---|---|
Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.
Topics: Adult; Cigarette Smoking; Comorbidity; Counseling; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Nicotinic Agonists; Patient Compliance; Rhode Island; Sex Factors; Smokers; Smoking Cessation; Substance-Related Disorders; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2017 |
Effects of varenicline versus transdermal nicotine replacement therapy on cigarette demand on quit day in individuals with substance use disorders.
Topics: Administration, Cutaneous; Adult; Craving; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Reinforcement, Psychology; Smoking; Smoking Cessation; Smoking Prevention; Substance-Related Disorders; Treatment Outcome; Varenicline | 2017 |
The effectiveness and safety of combining varenicline with nicotine e-cigarettes for smoking cessation in people with mental illnesses and addictions: study protocol for a randomised-controlled trial.
Topics: Adult; Combined Modality Therapy; Electronic Nicotine Delivery Systems; Female; Humans; Male; Mental Disorders; Motivation; New Zealand; Smoking; Smoking Cessation; Substance-Related Disorders; Treatment Outcome; Varenicline | 2018 |
Smoking quit success genotype score predicts quit success and distinct patterns of developmental involvement with common addictive substances.
Topics: Adolescent; Benzazepines; Bupropion; Case-Control Studies; Cohort Studies; Dose-Response Relationship, Drug; Female; Genotype; Humans; Male; Nicotine; Outcome Assessment, Health Care; Polymorphism, Single Nucleotide; Quinoxalines; Reproducibility of Results; Risk Factors; Smoking Cessation; Substance-Related Disorders; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline; Young Adult | 2014 |
Human abuse liability of the smoking cessation drug varenicline in smokers and nonsmokers.
Topics: Adult; Amphetamine; Benzazepines; Central Nervous System Stimulants; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Multivariate Analysis; Nicotinic Agonists; Odds Ratio; Quinoxalines; Reproducibility of Results; Smoking; Smoking Cessation; Substance-Related Disorders; Surveys and Questionnaires; Varenicline | 2008 |
9 other study(ies) available for varenicline and Chemical Dependence
| Article | Year |
|---|---|
Varenicline induced auditory hallucinations in a young female with bipolar disorder: a case report.
Topics: Bipolar Disorder; Female; Hallucinations; Humans; Nicotinic Agonists; Smoking; Smoking Cessation; Substance-Related Disorders; Tobacco Use Cessation Devices; Varenicline | 2023 |
The Persistent Challenge of Developing Addiction Pharmacotherapies.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Bupropion; Central Nervous System Stimulants; Cocaine-Related Disorders; Drug Therapy; Humans; Naltrexone; Narcotic Antagonists; Nicotinic Agonists; Smoking Cessation Agents; Substance-Related Disorders; Varenicline | 2021 |
Making lemonade from SARS coronavirus-2 lemons: Transitioning a smoking cessation trial to a virtual platform.
Topics: Adult; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; Counseling; COVID-19; Female; Humans; Internet; Male; Pandemics; Pneumonia, Viral; SARS-CoV-2; Smoking Cessation; Smoking Cessation Agents; Substance-Related Disorders; Telephone; Treatment Outcome; Varenicline | 2020 |
Varenicline and GZ-793A differentially decrease methamphetamine self-administration under a multiple schedule of reinforcement in rats.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Addictive; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Lobeline; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Reinforcement, Psychology; Self Administration; Substance-Related Disorders; Varenicline | 2018 |
Heteromeric nicotinic receptors are involved in the sensitization and addictive properties of MDMA in mice.
Topics: Analysis of Variance; Animals; Benzazepines; Brain; Cholinergic Agents; Conditioning, Operant; Dihydro-beta-Erythroidine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Hallucinogens; Hyperkinesis; Male; Mice; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Protein Binding; Quinoxalines; Radionuclide Imaging; Receptors, Nicotinic; Substance-Related Disorders; Tritium; Varenicline | 2013 |
Effects of varenicline on operant self-administration of alcohol and/or nicotine in a rat model of co-abuse.
Topics: Animals; Behavior, Addictive; Behavior, Animal; Conditioning, Operant; Disease Models, Animal; Drug Interactions; Ethanol; Male; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Substance-Related Disorders; Varenicline | 2016 |
Safety of Varenicline for Smoking Cessation in Psychiatric and Addicts Patients.
Topics: Adult; Counseling; Female; Humans; Longitudinal Studies; Male; Mental Disorders; Middle Aged; Prospective Studies; Smoking; Smoking Cessation; Substance-Related Disorders; Tobacco Use Cessation Devices; Varenicline | 2016 |
Assessing preferences for improved smoking cessation medications: a discrete choice experiment.
Topics: Adolescent; Adult; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Logistic Models; Male; Middle Aged; Models, Econometric; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Substance-Related Disorders; Surveys and Questionnaires; Switzerland; Varenicline; Young Adult | 2012 |
Drug addiction: a critical problem calling for novel solutions.
Topics: Benzazepines; Buprenorphine; Bupropion; Chronic Disease; Financing, Government; Genetic Testing; Harm Reduction; Humans; Marijuana Smoking; Naltrexone; Narcotic Antagonists; Prevalence; Privacy; Quinoxalines; Receptors, Nicotinic; Recurrence; Risk-Taking; Smoking; Smoking Cessation; Smoking Prevention; Social Environment; Substance-Related Disorders; Varenicline | 2008 |